What are the steps of the TADA (Topography, Architecture, Abnormalities, Dermoscopic features) method for dermoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TADA Method for Dermoscopy

The TADA (Triage Amalgamated Dermoscopic Algorithm) is a simplified 3-step dermoscopic algorithm designed for high sensitivity skin cancer detection, particularly useful for family physicians and frontline clinicians. 1, 2

Step I: Identify Unequivocal Benign Lesions

The first step requires unequivocal identification of dermoscopic features for one of three specific benign skin lesions: 1

  • Angioma - Look for red-purple lacunae or red-blue lagoons 1, 3
  • Dermatofibroma - Assess for firm palpation with dimpling and central white scar-like area 1, 2
  • Seborrheic keratosis/lentigo - Identify milia-like cysts, comedo-like openings, or fissures/ridges 1, 3

If any of these three benign lesions can be confidently identified, the lesion is classified as benign and no further steps are needed. 1, 2

Step II: Assess for Architectural Disorder

If Step I features are absent, evaluate for architectural disorder, defined as disorganized or asymmetric distribution of colors and/or structures. 2

The specific criteria to assess include: 2

  • Asymmetry of structures or colors
  • Disorganized distribution of dermoscopic features
  • Chaotic arrangement of pigmentation patterns

Step III: Evaluate for Malignancy-Specific Features

If architectural disorder is present, assess for specific dermoscopic criteria indicative of malignancy: 2

  • Starburst pattern 2
  • Blue-black or gray color 2
  • White structures (shiny white structures, regression) 2, 4
  • Negative network (angulated lines around hair follicles) 2
  • Ulceration 2
  • Vascular structures (dotted, polymorphous, or atypical vessels) 2, 4

The presence of any of these features warrants biopsy or specialist referral. 2

Diagnostic Performance

TADA demonstrates a sensitivity of 94.8% and specificity of 72.3% for malignant skin lesions after basic dermoscopy training. 2

  • Sensitivity for skin cancer increases from 62.5% to 88.1% following TADA training 3
  • Specificity reaches 87.8% post-training 3
  • Diagnostic accuracy improves from 76.4% to 90.8% for all lesions after introductory training 1

Critical Clinical Pearls

Previous dermoscopy experience is not required for effective TADA use - studies show no significant association between prior training and diagnostic sensitivity (P = 0.13) or specificity (P = 0.36). 2

Dedicated teaching time for benign lesions is essential - focusing on the three Step I benign neoplasms before malignancy training significantly improves overall diagnostic accuracy. 3

TADA has limitations with micromelanomas - 40% of melanomas ≤5.0 mm do not present melanoma-specific patterns, and the algorithm achieves only 64% detection of these small lesions compared to 96.61% for larger melanomas. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.